Atenolol/Spironolactone/Terazosin/ValsartanLack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50322-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[1] ValsartanLack of efficacy
Reactions Weekly, 2024, 2014 (1) : 647 - 647
[2] Sacubitril/valsartanLack of efficacy
Reactions Weekly, 2024, 1996 (1) : 202 - 202
[3] Sacubitril/valsartanLack of efficacy
Reactions Weekly, 2024, 1999 (1) : 337 - 337
[4] ValsartanLack of efficacy: case report
Reactions Weekly, 2023, 1943 (1) : 621 - 621
[5] Sacubitril/valsartanLack of efficacy : case report
Reactions Weekly, 2024, 2018 (1) : 417 - 417
[6] Sacubitril/valsartanLack of efficacy: case report
Reactions Weekly, 2023, 1945 (1) : 480 - 480
[7] Sacubitril/valsartanLack of efficacy: case report
Reactions Weekly, 2022, 1915 (1) : 386 - 386
[8] CONCOMITANT ADMINISTRATION OF TERAZOSIN AND ATENOLOL FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION
HOLTZMAN, JL
KAIHLANEN, PM
RIDER, JA
LEWIN, AJ
SPINDLER, JS
OBERLIN, JA
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (03) : 539 - 543
[9] Effects of terazosin and atenolol on plasma lipid levels in essential hypertension
Bur, A
Woisetschläger, C
Herkner, H
Derhaschnig, U
Quehenberger, P
Hirschl, MM
ZEITSCHRIFT FUR KARDIOLOGIE, 2002, 91 (09): : 685 - 692
[10] COMPARISON OF 3 TREATMENT REGIMENS IN PRIMARY HYPERTENSION - ATENOLOL, ATENOLOL PLUS SPIRONOLACTONE AND ATENOLOL PLUS PRAZOSIN
FALCH, DK
SOLHEIM, S
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1984, 35 (05): : 863 - 876

← 1 2 3 4 5 →